CONTENTS:
- Setting the stage for the inner journey: Unraveling the interplay of contextual factors and the intensity of psychedelic-induced ego dissolution. Adamczyk S., Paczynska M., Ruban A., Szczypinski J., Bola M., Orlowski P., p. 377-388.
- Psychedelic use and behavioral addictions. Brasher T., Rosen D., Spinella M., p. 389-402.
- Meaningful psychedelic experiences predict increased moral expansiveness. Olteanu W., Moreton S.G., p. 403-411.
- Therapeutic potential of psilocybin for treating neuropsychiatric long COVID symptoms: A Reddit investigation. Bobak L., Dorney I., Kovacevich A., Barnett B.S., p. 412-420.
- Kratom (Mitragyna speciosa Korth.) use among poly-drug users in Southeast Asia: A systematic review. Govarthnapany N., Gabrhelik R., Singh D., p. 421-431.
- Prevalence and use patterns of kratom (Mitragyna speciosa Korth.) in a US nationally representative sample. Grundmann O., Green M., Berthold E., Yoon S.L., Ray D., p. 432-440.
- Long-term mental health and wellbeing outcomes associated with naturalistic ayahuasca consumption. Pagni B.A., Halman A., Sarris J., Chenhall R., Bogenschutz M.P., Perkins D., p. 441-451.
- Exploring motivations, experiences, and consequences of psychedelic use in Aotearoa New Zealand. Mills E., Whelan J., McGruddy S., Ward R.D., p. 452-463.
- Therapeutic potential of psychedelics for treating anosmia: An investigation of online accounts. Kovacevich A., Dorney I., Bobak L., Kaelber D.C., Barnett B.S., p. 464-469.
- Prevalence and correlates of lifetime ecstasy/MDMA use among Asian American and Pacific Islander adult populations in the United States, 2015-2020. Kepner W., Yang K.H., Dionicio P., Bailey K., Satybaldiyeva N., Moore A., et al., p. 470-478.
- The healthcare profession as a determinant of depression, suicidal ideation, and drug use in Spain during the COVID-19 pandemic crisis. Villanueva-Blasco V.J.P., Lozano-Polo A.P., Guillamó Minguez C.P., Villanueva-Silvestre V.P., Isorna Folgar M.P., Gea-Caballero V.P., et al., p. 479-489.
- Vermont primary care provider perspectives on psychedelics - A cross-sectional study. Yalovitser J., Levine J., Zweber C., Tien L., Stultz M., Mitchell H., et al., p. 490-496.
- Interactions between depressive symptoms, childhood trauma, and drug craving in Chinese men with methamphetamine use disorder: A network analysis. Li D., Wang D., Tian Y., Chang Z., Chen J., Jia L., et al., p. 497-507.
- Prevalence of the prescribing of attention-deficit hyperactivity disorder medication during pregnancy: A systematic review. Russell D.J., Quintrell E., Wyrwoll C.S., Kelty E., p. 508-518.
- Prevalence and patterns of cannabis product adulteration: An analysis of WEDINOS data. Erridge S., Hall M., Sodergren M.H., p. 519-525.
- Methamphetamine use practices, motivations, and perceived benefits and risks: Exploring differences between males and females. Hooten M., Silverstein S., Daniulaityte R., p. 526-535.
- Combat veterans' experiences of moral injury, cannabis use disorder and the process of meaning-making: A mixed methods study. Loewenstein A., Asper A., Feingold D., p. 536-545.
- Patterns of tobacco use, dependence, and motivation to quit among individuals seeking treatment for alcohol and cannabis consumption in Catalonia (Spain). Martinez C., Saura J., Enriquez M., Feliu A., Roca X., Castellano Y., et al., p. 546-560.
- Factors of psychoactive substance use behaviors and intention among social workers' adolescent case-work clients in Hong Kong. Yu Y., Tse N., Ip T.K.M., Mo P.K.H., Lau J.T.F., p. 561-570.
- Lived experiences of nonmedical use of tramadol among urban slum-dwelling youth in Ghana: A qualitative study. Osei-Tutu S., Owusu-Sarpong O.J., Asante F., Siaw L.P., Gyasi R.M., p. 571-580.